Coeptis Therapeutics, Inc. Long-Term Debt, Maturity, after Year Five
Coeptis Therapeutics, Inc. had Long-Term Debt, Maturity, after Year Five of $144.79 thousand as of 2022-06-30, per its 10-Q filed 2022-08-02.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2022-08-02
- 2022-06-30: Long-Term Debt, Maturity, after Year Five $144.79K.
- 2022-03-31: Long-Term Debt, Maturity, after Year Five $147.82K.
- 2021-12-31: Long-Term Debt, Maturity, after Year Five $147.82K.
- 2021-09-30: Long-Term Debt, Maturity, after Year Five $134.04K.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2022-06-30 | $144.79K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $147.82K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $147.82K 10-K · filed 2022-03-11 |
| 2021-09-30 | $134.04K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $134.04K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $134.04K 10-Q/A · filed 2021-05-18 |